Promising Innovative Medicine (PIM)

The PIM designation provides an indication that a product may be eligible for the EAMS, based on early clinical data. Often, this PIM designation is issued after the MHRA has held a scientific meeting and this designation can be provided several years prior to the product being licensed.

All Glossary Entries